CLOV vs XOMAP · rev $1.37B vs P/E 25, rev $28.5M
Clover Health Investments Corp (CLOV) versus XOMA Royalty Corporation (XOMAP) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported XOMAP revenue for 2024-12-31 was $28.5M. Net income was -$13.8M. Revenue was up 498.7% from 2023-12-31 to 2024-12-31. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
CLOV currently screens at market cap $1.55B. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
Not investment advice. Open the CLOV and XOMAP stock pages for the full models.
Not investment advice.